# A Study to Assess the Efficacy of Inhaled Corticosteroid (ICS) Therapy in Moderate-Severe Bronchial Asthma

> **NCT00411567** · PHASE1,PHASE2 · COMPLETED · sponsor: **Novartis** · enrollment: 26 (—)

## Conditions studied

- Bronchial Asthma

## Interventions

- **DRUG:** inhaled corticosteroid therapy

## Key facts

- **NCT ID:** NCT00411567
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 26 (—)
- **Last updated:** 2007-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00411567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00411567, "A Study to Assess the Efficacy of Inhaled Corticosteroid (ICS) Therapy in Moderate-Severe Bronchial Asthma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00411567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*